Taj Asma, Abbi Kamal, Skeel Roland T
University of Toledo Medical Center, Toledo, OH.
Am J Ther. 2015 Jan-Feb;22(1):e6-7. doi: 10.1097/MJT.0b013e318293b269.
Thalidomide is one of the immunomodulating agents used in current oncology practice. We present a case of hemorrhagic rash induced by thalidomide in a patient with delta granule storage pool disease. The patient was getting thalidomide for underlying myelofibrosis.